98 related articles for article (PubMed ID: 19562734)
1. Modeling the effects of obesity and weight gain on PSA velocity.
Rundle AG; Neugut AI
Prostate; 2009 Oct; 69(14):1573-8. PubMed ID: 19562734
[TBL] [Abstract][Full Text] [Related]
2. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
4. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.
Kristal AR; Chi C; Tangen CM; Goodman PJ; Etzioni R; Thompson IM
Cancer; 2006 Jan; 106(2):320-8. PubMed ID: 16342294
[TBL] [Abstract][Full Text] [Related]
5. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
6. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
7. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
[TBL] [Abstract][Full Text] [Related]
8. The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance.
Choi HC; Park JH; Cho BL; Son KY; Yoo YJ; Kwon HT
BJU Int; 2011 Dec; 108(11):1756-61. PubMed ID: 21507191
[TBL] [Abstract][Full Text] [Related]
9. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
10. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prostate-specific antigen and hematocrit: does hemodilution lead to lower PSA concentrations in men with a higher body mass index?
Ohwaki K; Endo F; Muraishi O; Hiramatsu S; Yano E
Urology; 2010 Mar; 75(3):648-52. PubMed ID: 19854477
[TBL] [Abstract][Full Text] [Related]
12. Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men.
Chang IH; Han JH; Ahn SH
J Urol; 2008 Mar; 179(3):886-90; discussion 890-1. PubMed ID: 18207169
[TBL] [Abstract][Full Text] [Related]
13. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
[TBL] [Abstract][Full Text] [Related]
15. Body composition, abdominal fat distribution, and prostate-specific antigen test results.
Rundle A; Richards C; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):331-6. PubMed ID: 19124516
[TBL] [Abstract][Full Text] [Related]
16. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer.
Skolarus TA; Wolin KY; Grubb RL
Nat Clin Pract Urol; 2007 Nov; 4(11):605-14. PubMed ID: 17982437
[TBL] [Abstract][Full Text] [Related]
17. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
[TBL] [Abstract][Full Text] [Related]
18. Plasma volume changes affect prostate specific antigen in healthy men.
Ohwaki K; Endo F; Muraishi O; Yano E
J Urol; 2010 Apr; 183(4):1349-53. PubMed ID: 20171686
[TBL] [Abstract][Full Text] [Related]
19. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
Elmansy HM; Elzayat EA; Sampalis JS; Elhilali MM
Urology; 2009 Nov; 74(5):1105-10. PubMed ID: 19773035
[TBL] [Abstract][Full Text] [Related]
20. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
